Chaim Sheba Medical Center; Oncology Dept
About Chaim Sheba Medical Center; Oncology Dept
Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.
There are 1,580 beds in Chaim Sheba Medical Center; Oncology Dept.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
21
Merck Sharp & Dohme LLC
3
Genentech, Inc.
1
Clinical Trials at Chaim Sheba Medical Center; Oncology Dept
During the past decade, Chaim Sheba Medical Center; Oncology Dept conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on
average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy
2011-05-23
2016-12-20
Completed
60
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
2012-01-20
2016-03-30
Completed
501
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,068
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
2013-11-19
2017-07-19
Completed
102
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Chaim Sheba Medical Center; Oncology Dept"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Clalit Health Services" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Chaim Sheba Medical Center; Oncology Dept
According to Clinical.Site data, the most researched conditions in "Chaim Sheba Medical Center; Oncology Dept" are
"Non-Small Cell Lung Cancer" (4 trials), "Breast Cancer" (3 trials), "Asthma" (1 trials), "Biliary Tract Neoplasms" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Chaim Sheba Medical Center; Oncology Dept" in a lesser frequency.
Clinical Trials Intervention Types at Chaim Sheba Medical Center; Oncology Dept
Most popular intervention types in "Chaim Sheba Medical Center; Oncology Dept" are "Drug" (25 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (9 trials), "Carboplatin" (7 trials), "Docetaxel" (6 trials), "Paclitaxel" (6 trials) and "Cisplatin" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Chaim Sheba Medical Center; Oncology Dept
The vast majority of trials in "Chaim Sheba Medical Center; Oncology Dept" are
24 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Chaim Sheba Medical Center; Oncology Dept
Currently, there are NaN active trials in "Chaim Sheba Medical Center; Oncology Dept".
undefined are not yet recruiting,
8 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Chaim Sheba Medical Center; Oncology Dept,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chaim Sheba Medical Center; Oncology Dept, 2 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".